Ruth Halaban
Ruth Halaban
Verified email at
Cited by
Cited by
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, B ŠArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma
M Krauthammer, Y Kong, BH Ha, P Evans, A Bacchiocchi, JP McCusker, ...
Nature genetics 44 (9), 1006-1014, 2012
In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma
FA Karreth, Y Tay, D Perna, U Ala, SM Tan, AG Rust, G DeNicola, ...
Cell 147 (2), 382-395, 2011
Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes.
R Halaban, R Langdon, N Birchall, C Cuono, A Baird, G Scott, ...
The Journal of cell biology 107 (4), 1611-1619, 1988
Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas
K Hoek, DL Rimm, KR Williams, H Zhao, S Ariyan, A Lin, HM Kluger, ...
Cancer research 64 (15), 5270-5282, 2004
Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus.
BS Kwon, AK Haq, SH Pomerantz, R Halaban
Proceedings of the National Academy of Sciences 84 (21), 7473-7477, 1987
Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure
S Premi, S Wallisch, CM Mano, AB Weiner, A Bacchiocchi, K Wakamatsu, ...
Science 347 (6224), 842-847, 2015
Combination therapy with anti–CTLA-4 and anti–PD-1 leads to distinct immunologic changes in vivo
R Das, R Verma, M Sznol, CS Boddupalli, SN Gettinger, H Kluger, ...
The Journal of Immunology 194 (3), 950-959, 2015
Exome sequencing identifies recurrent mutations in NF1 and RASopathy genes in sun-exposed melanomas
M Krauthammer, Y Kong, A Bacchiocchi, P Evans, N Pornputtapong, ...
Nature genetics 47 (9), 996-1002, 2015
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
J Yuan, M Adamow, BA Ginsberg, TS Rasalan, E Ritter, HF Gallardo, Y Xu, ...
Proceedings of the National Academy of Sciences 108 (40), 16723-16728, 2011
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
MF Sanmamed, JL Perez-Gracia, KA Schalper, JP Fusco, A Gonzalez, ...
Annals of Oncology 28 (8), 1988-1995, 2017
VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors†…
T Cohen, H Gitay-Goren, R Sharon, M Shibuya, R Halaban, BZ Levi, ...
Journal of Biological Chemistry 270 (19), 11322-11326, 1995
PLX4032, a selective BRAFV600E kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAFWT melanoma cells
R Halaban, W Zhang, A Bacchiocchi, E Cheng, F Parisi, S Ariyan, ...
Pigment cell & melanoma research 23 (2), 190-200, 2010
UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells.
DB Bregman, R Halaban, AJ Van Gool, KA Henning, EC Friedberg, ...
Proceedings of the National Academy of Sciences 93 (21), 11586-11590, 1996
Regulation of tyrosinase in human melanocytes grown in culture.
R Halaban, SH Pomerantz, S Marshall, DT Lambert, AB Lerner
The Journal of cell biology 97 (2), 480-488, 1983
bFGF as an autocrine growth factor for human melanomas.
R Halaban, BS Kwon, S Ghosh, A Baird
Oncogene research 3 (2), 177-186, 1988
Early B cell changes predict autoimmunity following combination immune checkpoint blockade
R Das, N Bar, M Ferreira, AM Newman, L Zhang, JK Bailur, A Bacchiocchi, ...
The Journal of clinical investigation 128 (2), 715-720, 2018
bFGF is the putative natural growth factor for human melanocytes
R Halaban, S Ghosh, A Baird
In vitro cellular & developmental biology 23, 47-52, 1987
Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis
BJ Longley Jr, GS Morganroth, L Tyrrell, TG Ding, DM Anderson, ...
New England Journal of Medicine 328 (18), 1302-1307, 1993
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
JC Rubinstein, M Sznol, AC Pavlick, S Ariyan, E Cheng, A Bacchiocchi, ...
Journal of translational medicine 8, 1-3, 2010
The system can't perform the operation now. Try again later.
Articles 1–20